Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-08-12 09:46:21 UTC |
---|
Updated at | 2024-09-16 10:47:02 UTC |
---|
NP-MRD ID | NP0333728 |
---|
Natural Product DOI | https://doi.org/10.57994/3207 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 6-O-ethylzephyranine F |
---|
Description | It was first documented in 2024 (PMID: 39313673). Based on a literature review a significant number of articles have been published on 6-O-ethylzephyranine F (PMID: 39313534) (PMID: 39313496) (PMID: 39313329) (PMID: 39313328). |
---|
Structure | [H][C@]12C[C@H](CC[C@@]11CCN2[C@@H](OCC)C2=CC(OC)=C(OC)C(O)=C12)OC InChI=1S/C20H29NO5/c1-5-26-19-13-11-14(24-3)18(25-4)17(22)16(13)20-7-6-12(23-2)10-15(20)21(19)9-8-20/h11-12,15,19,22H,5-10H2,1-4H3/t12-,15-,19-,20+/m0/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C20H29NO5 |
---|
Average Mass | 363.4540 Da |
---|
Monoisotopic Mass | 363.20457 Da |
---|
IUPAC Name | (1S,8S,10S,12S)-8-ethoxy-4,5,12-trimethoxy-9-azatetracyclo[7.5.2.0^{1,10}.0^{2,7}]hexadeca-2,4,6-trien-3-ol |
---|
Traditional Name | (1S,8S,10S,12S)-8-ethoxy-4,5,12-trimethoxy-9-azatetracyclo[7.5.2.0^{1,10}.0^{2,7}]hexadeca-2,4,6-trien-3-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@]12C[C@H](CC[C@@]11CCN2[C@@H](OCC)C2=CC(OC)=C(OC)C(O)=C12)OC |
---|
InChI Identifier | InChI=1S/C20H29NO5/c1-5-26-19-13-11-14(24-3)18(25-4)17(22)16(13)20-7-6-12(23-2)10-15(20)21(19)9-8-20/h11-12,15,19,22H,5-10H2,1-4H3/t12-,15-,19-,20+/m0/s1 |
---|
InChI Key | HRRSARMGLRWMTJ-CCQDZNTNSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
NOESY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | H2BC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, CDCL3, experimental) | marikoj2@faf.cuni.cz | Faculty of Pharmacy, Charles University | Jana Křoustková | 2024-08-12 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
citrina | | |
|
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Nandi A, Nakano M, Brasic JR, Brinson ZS, Kitzmiller K, Mathur A, Mohamed M, Roberts J, Wong DF, Kuwabara H: Improved Quantification of MicroPET/CT Imaging Using CT-derived Scaling Factors. Mol Imaging Biol. 2024 Sep 23. doi: 10.1007/s11307-024-01947-5. [PubMed:39313673 ]
- Langer F, Binter M, Hu X, Hufendiek K, Meister R, Tode J, Framme C, Fuchs H: In vitro comparison of human and murine trabecular meshwork cells: implications for glaucoma research. Sci Rep. 2024 Sep 23;14(1):22002. doi: 10.1038/s41598-024-73057-9. [PubMed:39313534 ]
- Hegab MAE: Mineral exploration and environmental impact assessment in the Jabal Hamadat Area, Central Eastern Desert, Egypt, using remote sensing and airborne radiometric data. Sci Rep. 2024 Sep 23;14(1):21986. doi: 10.1038/s41598-024-71387-2. [PubMed:39313496 ]
- Whitlock BD, Ma Y, Conseil G, O'Brien AR, Banerjee M, Swanlund DP, Lin ZP, Wang Y, Le XC, Schuetz JD, Cole SPC, Leslie EM: Differential Selectivity of Human and Mouse ABCC4/Abcc4 for Arsenic Metabolites. Drug Metab Dispos. 2024 Sep 23:DMD-AR-2024-001852. doi: 10.1124/dmd.124.001852. [PubMed:39313329 ]
- Glaenzel U, Huth F, Eggimann F, Hackling M, Leuthold LA, Meissner A, Bebrevska L: Absorption, Distribution, Metabolism, and Excretion of Icenticaftor (QBW251) in Healthy Male Volunteers at Steady State and In Vitro Phenotyping of Major Metabolites. Drug Metab Dispos. 2024 Sep 23:DMD-AR-2024-001751. doi: 10.1124/dmd.124.001751. [PubMed:39313328 ]
|
---|